National medicine regulator, the Food and Drug Administration (FDA), recently approved the world's first vaccines to prevent RSV, or respiratory syncytial virus, for infants and elderly adults.
Sep 14, 2023
0
12
Canada on Tuesday approved an updated Moderna COVID vaccine targeting new variants, and is reviewing others likely to be rolled out this fall to mitigate infections once more on the rise.
Sep 12, 2023
0
2
Respiratory syncytial virus (RSV) is a common viral infection that affects people of all ages, with infants and older adults being particularly vulnerable to severe complications.
Sep 7, 2023
0
1
A new COVID variant is circulating. Flu season is about to begin. Respiratory syncytial virus (known as RSV) is becoming a greater cause of hospitalizations.
Sep 6, 2023
1
24
TWINCORE researchers describe a mechanism that inhibits virus replication and protects cells from damage. Interestingly, a drug that has already been approved could prove useful in combating various viruses.
Aug 31, 2023
0
49
With the Food and Drug Administration's Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have a major new tool at its disposal to ...
Aug 28, 2023
0
6
The EU on Friday authorized the sale of a vaccine to protect infants from respiratory syncytial virus (RSV), a disease that in worst cases can lead to pneumonia and bronchiolitis.
Aug 25, 2023
0
4
The Food and Drug Administration has approved a vaccine for pregnant women to provide immediate protection against respiratory syncytial virus, or RSV, in infants.
Aug 22, 2023
0
3
The first Americans over age 60 just started rolling up their sleeves to get vaccinated against respiratory syncytial virus, or RSV, now that brand-new vaccines have started to arrive at pharmacies and clinics.
Aug 22, 2023
1
2
A simple blood test which may be able to rapidly diagnose the cause of a child's illness could be "transformative," say researchers.
Aug 18, 2023
0
46
